TayganPoint Consulting Group and PharmaVoice conduct survey to uncover pharma executive’s challenges
First published April 25, 2018
WASHINGTON CROSSING, Pa.–(BUSINESS WIRE)–There are a number of market factors that are impacting life-sciences companies today. CEOs and other C-Suite executives must manage pressures being driven by a changing customer landscape (patients, providers, payers); heightened focus on pricing and value; and increasing competition not only from traditional peers but from new entrants looking to disrupt the industry.
Because of these external pressures as well as internally driven factors, such as the need to be more cost-effective without losing efficiency, many life-sciences companies are engaging in or considering moderate to large-scale transformation in the next three years. The primary areas companies are considering transformative changes are in marketing, sales, R&D, and technology and IT.
In mid-September 2017, TayganPoint Consulting Group and PharmaVoice conducted a follow-on research study to gather data around business transformation — the challenges, pressures, motivations, resources — and the needs of companies as the progress through their transformation process.